News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
754,647 Results
Type
Article (44469)
Company Profile (312)
Press Release (709852)
Multimedia
Podcasts (135)
Webinars (22)
Section
Business (211270)
Career Advice (2120)
Deals (36866)
Drug Delivery (148)
Drug Development (83659)
Employer Resources (176)
FDA (16962)
Job Trends (15555)
News (358031)
Policy (34158)
Tag
2027 BioCapital Elite (1)
2027 BioCapital Standard (1)
2027 BioMidwest Elite (1)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (2)
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (3)
2027 Pharm Country Elite (2)
2027 Pharm Country Standard (6)
Academia (2653)
Accelerated approval (55)
ADA (44)
Adcomms (31)
Allergies (198)
Alliances (51595)
ALS (231)
Alzheimer's disease (1857)
Antibody-drug conjugate (ADC) (534)
Approvals (17440)
Artificial intelligence (754)
ASCO (333)
Autoimmune disease (347)
Automation (64)
Bankruptcy (375)
Best Places to Work (11768)
BIO (66)
BIOSECURE Act (21)
Biosimilars (240)
Biotechnology (184)
Bladder cancer (204)
Brain cancer (79)
Breast cancer (813)
Cancer (6382)
Cardiovascular disease (519)
Career advice (1810)
Career pathing (45)
CAR-T (360)
CDC (61)
Celiac Disease (3)
Cell therapy (976)
Cervical cancer (56)
Clinical research (73143)
Collaboration (2263)
Commercialization (1)
Company closure (5)
Compensation (1499)
Complete response letters (92)
COVID-19 (2828)
CRISPR (122)
C-suite (1266)
Cystic fibrosis (161)
Data (8683)
Decentralized trials (3)
Denatured (41)
Depression (178)
Dermatology (97)
Diabetes (669)
Diagnostics (7115)
Digital health (63)
Diversity (13)
Diversity, equity & inclusion (45)
Drug discovery (372)
Drug pricing (222)
Drug shortages (34)
Duchenne muscular dystrophy (307)
Earnings (93960)
Editorial (70)
Employer branding (21)
Employer resources (156)
Events (123588)
Executive appointments (1154)
FDA (21018)
Fibrodysplasia Ossificans Progressiva (9)
Friedreich's ataxia (22)
Frontotemporal dementia (35)
Funding (1871)
Gene editing (252)
Generative AI (64)
Gene therapy (772)
GLP-1 (1146)
Government (4898)
Grass and pollen (7)
Guidances (420)
Healthcare (19334)
Hematology (195)
HIV (90)
Huntington's disease (62)
IgA nephropathy (113)
Immunology and inflammation (314)
Immuno-oncology (106)
Indications (218)
Infectious disease (3196)
Inflammatory bowel disease (230)
Inflation Reduction Act (14)
Influenza (142)
Intellectual property (322)
Interviews (332)
IPO (16961)
IRA (57)
Job creations (4077)
Job search strategy (1502)
JPM (65)
Kidney cancer (20)
Labor market (112)
Layoffs (604)
Leadership (44)
Legal (8428)
Liver cancer (104)
Longevity (36)
Lung cancer (842)
Lymphoma (479)
Machine learning (67)
Management (61)
Manufacturing (1183)
Marketing (4)
MASH (215)
Medical affairs (1)
Medical device (14077)
Medtech (14247)
Mergers & acquisitions (21213)
Metabolic disorders (1686)
mRNA (240)
Multiple sclerosis (200)
NASH (18)
Neurodegenerative disease (464)
Neuropsychiatric disorders (115)
Neuroscience (3523)
Neurotech (1)
NextGen: Class of 2026 (6650)
Non-profit (4587)
Now hiring (82)
Obesity (782)
Opinion (321)
Ovarian cancer (240)
Pain (283)
Pancreatic cancer (352)
Parkinson's disease (394)
Partnered (36)
Patents (643)
Patient recruitment (767)
Peanut (70)
People (61946)
Pharmaceutical (85)
Pharmacy benefit managers (35)
Phase 1 (22705)
Phase 2 (32197)
Phase 3 (24089)
Pipeline (9893)
Policy (349)
Postmarket research (2661)
Preclinical (9666)
Press Release (68)
Prostate cancer (336)
Psychedelics (61)
Radiopharmaceuticals (352)
Rare diseases (1212)
Real estate (6324)
Recruiting (72)
Regulatory (26730)
Reports (57)
Research institute (2474)
Resumes & cover letters (363)
Rett syndrome (46)
RNA editing (27)
RSV (90)
Schizophrenia (191)
Series A (320)
Series B (237)
Service/supplier (11)
Sickle cell disease (123)
Special edition (27)
Spinal muscular atrophy (171)
Sponsored (49)
Startups (3800)
State (2)
Stomach cancer (19)
Supply chain (137)
Tariffs (99)
The Weekly (92)
Vaccines (1174)
Venture capital (124)
Weight loss (509)
Women's health (139)
Worklife (21)
Date
Today (123)
Last 7 days (472)
Last 30 days (2453)
Last 365 days (30784)
2026 (16336)
2025 (30674)
2024 (35760)
2023 (40627)
2022 (51801)
2021 (56326)
2020 (54788)
2019 (47394)
2018 (35767)
2017 (33134)
2016 (32661)
2015 (38615)
2014 (32516)
2013 (27631)
2012 (29729)
2011 (30487)
2010 (28497)
Location
Africa (807)
Alabama (93)
Alaska (7)
Arizona (373)
Arkansas (16)
Asia (42879)
Australia (6885)
California (14068)
Canada (3987)
China (1534)
Colorado (598)
Connecticut (614)
Delaware (437)
Europe (92353)
Florida (2120)
Georgia (446)
Hawaii (3)
Idaho (63)
Illinois (1169)
India (101)
Indiana (643)
Iowa (25)
Japan (611)
Kansas (135)
Kentucky (51)
Louisiana (60)
Maine (76)
Maryland (1670)
Massachusetts (10123)
Michigan (379)
Minnesota (762)
Mississippi (6)
Missouri (148)
Montana (33)
Nebraska (30)
Nevada (150)
New Hampshire (84)
New Jersey (3687)
New Mexico (31)
New York (3701)
North Carolina (1789)
North Dakota (9)
Northern California (7093)
Ohio (419)
Oklahoma (24)
Oregon (46)
Pennsylvania (2801)
Puerto Rico (31)
Rhode Island (52)
South America (1180)
South Carolina (88)
South Dakota (2)
Southern California (5577)
Tennessee (229)
Texas (2260)
United States (49735)
Utah (417)
Vermont (2)
Virginia (359)
Washington D.C. (81)
Washington State (1120)
West Virginia (4)
Wisconsin (143)
Wyoming (2)
754,647 Results for "actinium pharmaceuticals inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Niowave, Inc. and Ratio Therapeutics Sign Supply Agreement for Actinium-225 to Advance Targeted Alpha Therapies
June 17, 2026
·
3 min read
Press Releases
TerraPower Isotopes Breaks Ground on World’s Largest Actinium-225 Manufacturing Facility in Philadelphia
May 7, 2026
·
4 min read
Press Releases
NorthStar and QSA Global Announce Multi-Year Strategic Partnership to Strengthen Actinium-225 Supply Chain for Targeted Alpha Therapies
May 27, 2026
·
4 min read
Press Releases
NorthStar Secures FDA Acceptance of Drug Master File for No-Carrier-Added Actinium-225
April 15, 2026
·
3 min read
Press Releases
Cardinal Health expands Actinium-225 production capacity to support growing demand for novel cancer therapies
April 1, 2026
·
3 min read
Manufacturing
Radiopharma Sector Races To Secure Actinium-225 Supply as Pipelines Expand
Suppliers are investing in production to support deals with AstraZeneca, Bayer and other drugmakers that are advancing radioisotope-based cancer therapies.
February 17, 2026
·
4 min read
·
Nick Paul Taylor
Manufacturing
Niowave, fresh from Novartis deal, starts building $75M radioisotope plant
Having secured deals with AstraZeneca and Novartis, Niowave is constructing a second facility to meet rising demand for actinium-225, which can be used to develop next-generation radiopharmaceuticals.
May 26, 2026
·
2 min read
·
Nick Paul Taylor
Press Releases
Niowave and Novartis Enter Global Actinium-225 Supply Agreement to Advance Next-Generation Cancer Therapies
February 11, 2026
·
2 min read
Manufacturing
TerraPower Commits $450M To Build Radioisotope Production Plant
Constructing the cGMP facility will increase availability of actinium-225, a nuclear material central to radiopharmaceutical programs at AstraZeneca, Bristol Myers Squibb, Eli Lilly and Novartis.
March 18, 2026
·
2 min read
·
Nick Paul Taylor
Press Releases
BIOEMTECH and NorthStar Medical Radioisotopes Announce Strategic Supply Agreement for Actinium-225 to Support Preclinical Radiopharmaceutical Research
February 17, 2026
·
3 min read
1 of 75,465
Next
